Oxalate in renal stone disease: the terminal metabolite that just won't go away

Scales CD Jr et al. (2007) Changing gender prevalence of stone disease. J Urol 177: 979–982

Curhan GC (2007) Epidemiology of stone disease. Urol Clin North Am 34: 287–293

Worcester EM et al. (2006) Renal function in patients with nephrolithiasis. J Urol 176: 600–603

Gillen DL et al. (2005) Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int 67: 685–690

Krambeck AE et al. (2006) Diabetes mellitus and hypertension associated with shock wave lithotripsy of renal and proximal ureteral stones at 19 years of followup. J Urol 175: 1742–1747

Vupputuri S et al. (2004) History of kidney stones as a possible risk factor for chronic kidney disease. Ann Epidemiol 14: 222–228

Mente A et al. (2006) High urinary calcium excretion and genetic susceptibility to hypertension and kidney stone disease. J Am Soc Nephrol 17: 2567–2575

Evan AP et al. (2003) Randall's plaque of patients with nephrolithiasis begins in basement membranes of thin loops of Henle. J Clin Invest 111: 607–616

Evan AP et al. (2007) Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec (Hoboken) 290: 1315–1323

Evan A et al. (2006) Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int 69: 1313–1318

Asplin JR and Coe FL (2007) Hyperoxaluria in kidney stone-formers treated with modern bariatric surgery. J Urol 177: 565–569

Sinha MK et al. (2007) Hyperoxaluric nephrolithiasis is a complication of Roux-en-Y gastric bypass surgery. Kidney Int 72: 100–107

Mole DR et al. (2001) Renal complications of jejuno-ileal bypass for obesity. QJM 94: 69–77

Hassan I et al. (2001) Chronic renal failure secondary to oxalate nephropathy: a preventable complication after jejunoileal bypass. Mayo Clin Proc 76: 758–760

Asplin JR (2002) Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin North Am 31: 927–949

Hatch M and Freel RW (2005) Intestinal transport of an obdurate anion: oxalate. Urol Res 33: 1–16

Smith LHJ et al. (1972) Inhibition of oxalate synthesis: in vitro studies using analogues of oxalate and glycolate. Biochem Med 6: 317–332

Jennings ML and Adame MF (1996) Characterization of oxalate transport by the human erythrocyte band 3 protein. J Gen Physiol 107: 145–159

Holmes RP et al. (2001) Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 59: 270–276

Soleimani M (2006) Expression, regulation and the role of SLC26 Cl−/HCO3− exchangers in kidney and gastrointestinal tract. Novartis Found Symp 273: 91–102

Mount DB and Romero MF (2004) The SLC26 gene family of multifunctional anion exchangers. Pflugers Arch 447: 710–721

Jaeger P and Robertson WG (2004) Role of dietary intake and intestinal absorption of oxalate in calcium stone formation. Nephron Physiol 98: 64–71

Hautmann RE (1993) The stomach: a new and powerful oxalate absorption site in man. J Urol 149: 1401–1404

Lohi H et al. (2002) Functional characterization of three novel tissue-specific anion exchangers SLC26A7, -A8, and -A9. J Biol Chem 277: 14246–14254

Freel RW et al. (2006) Ileal oxalate absorption and urinary oxalate excretion are enhanced in Slc26a6 null mice. Am J Physiol Gastrointest Liver Physiol 290: G719–G728

Jiang Z et al. (2006) Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat Genet 38: 474–478

Thomas E et al. (2007) Influence of a low- and a high-oxalate vegetarian diet on intestinal oxalate absorption and urinary excretion. Eur J Clin Nutr [10.1038/sj.ejcn.1602832]

Knight J et al. (2007) Intestinal and renal handling of oxalate loads in normal individuals and stone-formers. Urol Res 35: 111–117

Massey LK (2007) Food oxalate: factors affecting measurement, biological variation, and bioavailability. J Am Diet Assoc 107: 1191–1195

Lewandowski S and Rodgers AL (2004) Idiopathic calcium oxalate urolithiasis: risk factors and conservative treatment. Clin Chim Acta 345: 17–34

Grases F et al. (2006) Renal lithiasis and nutrition. Nutr J 5: 23

Emmett M et al. (2003) Conjugated bile acid replacement therapy reduces urinary oxalate excretion in short bowel syndrome. Am J Kidney Dis 41: 230–237

Hoppe B et al. (2005) Oxalate degrading bacteria: new treatment option for patients with primary and secondary hyperoxaluria? Urol Res 33: 372–375

Voss S et al. (2006) Intestinal oxalate absorption is higher in idiopathic calcium oxalate stone-formers than in healthy controls: measurements with the [13C2]oxalate absorption test. J Urol 175: 1711–1715

Baker PR et al. (2004) Glycolate and glyoxylate metabolism in HepG2 cells. Am J Physiol Cell Physiol 287: C1359–C1365

Behnam JT et al. (2006) Reconstruction of human hepatocyte glyoxylate metabolic pathways in stably transformed Chinese-hamster ovary cells. Biochem J 394: 406–416

Knight J et al. (2006) Hydroxyproline ingestion and urinary oxalate and glycolate excretion. Kidney Int 70: 1929–1934

Danpure CJ (2006) Primary hyperoxaluria type 1: AGT mistargeting highlights the fundamental differences between the peroxisomal and mitochondrial protein import pathways. Biochim Biophys Acta 1763: 1776–1784

Webster KE et al. (2000) Identification of missense, nonsense, and deletion mutations in the GRHPR gene in patients with primary hyperoxaluria type II (PH2). Hum Genet 107: 176–185

van Woerden CS et al. (2006) High incidence of hyperoxaluria in generalized peroxisomal disorders. Mol Genet Metab 88: 346–350

Linster CL and Van Schaftingen E (2007) Vitamin C: biosynthesis, recycling and degradation in mammals. FEBS J 274: 1–22

Massey LK et al. (2005) Ascorbate increases human oxaluria and kidney stone risk. J Nutr 135: 1673–1677

Micali S et al. (2006) Medical therapy of urolithiasis. J Endourol 20: 841–847

Greger R et al. (1978) Handling of oxalate by the rat kidney. Pflugers Arch 374: 243–248

Boer P et al. (1985) Fractional oxalate clearance in subjects with normal and impaired renal function. Nephron 41: 78–81

Prenen JA et al. (1985) Plasma oxalate concentration and oxalate distribution volume in patients with normal and decreased renal function. Eur J Clin Invest 15: 45–49

Sugimoto T et al. (1993) Fate of circulating oxalate in rats. Eur Urol 23: 485–489

Curhan GC et al. (2001) Twenty-four-hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 59: 2290–2298

Prenen JA et al. (1981) Determination of oxalic acid clearance and plasma concentration by radioisotope infusion: results in a family with hyperoxaluria. Acta Med Scand 209: 87–91

Osswald H and Hautmann R (1979) Renal elimination kinetics and plasma half-life of oxalate in man. Urol Int 34: 440–450

Watts RW et al. (1984) Oxalate dynamics and removal rates during haemodialysis and peritoneal dialysis in patients with primary hyperoxaluria and severe renal failure. Clin Sci (Lond) 66: 591–597

Hatch M and Freel RW (2003) Renal and intestinal handling of oxalate following oxalate loading in rats. Am J Nephrol 23: 18–26

Costello JF et al. (1992) Extrarenal clearance of oxalate increases with progression of renal failure in the rat. J Am Soc Nephrol 3: 1098–1104

Marengo SR et al. (2006) Continuous infusion of oxalate by minipumps induces calcium oxalate nephrocalcinosis. Urol Res 34: 200–210

Curtin CO and King CG (1955) The metabolism of ascorbic acid-1-C14 and oxalic acid-C14 in the rat. J Biol Chem 216: 539–548

Weinhouse S and Friedmann B (1951) Metabolism of labeled 2-carbon acids in the intact rat. J Biol Chem 191: 707–717

Costello JF and Smith M (1992) Determination of evolved 14CO2 in decarboxylase reactions with application to measurement of [14C]oxalic acid. Anal Biochem 202: 337–339

Hatch M et al. (2006) Oxalobacter sp. reduces urinary oxalate excretion by promoting enteric oxalate secretion. Kidney Int 69: 691–698

Hoppe B et al. (2006) Oxalobacter formigenes: a potential tool for the treatment of primary hyperoxaluria type 1. Kidney Int 70: 1305–1311

Markovich D (2001) Physiological roles and regulation of mammalian sulfate transporters. Physiol Rev 81: 1499–1533

Markovich D and Aronson PS (2007) Specificity and regulation of renal sulfate transporters. Annu Rev Physiol 69: 361–375

Knight TK et al. (1981) Oxalate secretion in the rat proximal tubule. Am J Physiol Cell Physiol 240: F295–F298

Robertson WG (2004) Kidney models of calcium oxalate stone formation. Nephron Physiol 98: 21–30

Kok DJ (1996) Crystallization and stone formation inside the nephron. Scanning Microsc 10: 471–486

Sigmon D et al. (1991) Oxalate transport in renal tubular cells from normal and stone-forming animals. Am J Kidney Dis 17: 376–380

Chandhoke PS and Fan J (2000) Transport of oxalate across the rabbit papillary surface epithelium. J Urol 164: 1724–1728

Aronson PS and Giebish G (1997) Mechanisms of chloride transport in the proximal tubule. Am J Physiol 273: F179–F192

Wang T et al. (1996) Mechanisms of the proximal tubule chloride transport by formate and oxalate. Am J Physiol 271: F446–F450

Hassan HA et al. (2007) Regulation of anion exchanger Slc26a6 by protein kinase C. Am J Physiol Cell Physiol 292: C1485–C1492

Burckhardt BC and Burckhardt G (2003) Transport of organic anions across the basolateral membrane of proximal tubule cells. Rev Physiol Biochem Pharmacol 146: 95–158

Kuo SM and Aronson PS (1988) Oxalate transport via the sulfate/HCO3 exchanger in rabbit renal basolateral membrane vesicles. J Biol Chem 263: 9710–9717

Lee A et al. (2005) NaSi-1 and Sat-1: structure, function and transcriptional regulation of two genes encoding renal proximal tubular sulfate transporters. Int J Biochem Cell Biol 37: 1350–1356

Linsdell P (2006) Mechanism of chloride permeation in the cystic fibrosis transmembrane conductance regulator chloride channel. Exp Physiol 91: 123–129

Ko SB et al. (2004) Gating of CFTR by the STAS domain of SLC26 transporters. Nat Cell Biol 6: 292–294

Terribile M et al. (2006) Factors increasing the risk for stone formation in adult patients with cystic fibrosis. Nephrol Dial Transplant 21: 1870–1875

Bushinsky DA et al. (2002) Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 61: 975–987

Coe FL et al. (2005) Kidney stone disease. J Clin Invest 115: 2598–2608

Preminger GM (2003) Oxaluria–the neglected stepchild of nephrolithiasis? J Urol 170: 402–403

Turner MA et al. (2000) Oxalate and calcium excretion in cystic fibrosis. Arch Dis Child 83: 244–247

Terribile M et al. (2006) Factors increasing the risk for stone formation in adult patients with cystic fibrosis. Nephrol Dial Transplant 21: 1870–1875

Asplin JR and Coe FL (2006) Hyperoxaluria in bariatric surgery patients with urolithiasis [abstract #1040]. J Urol 175: a334

Robertson WG and Hughes H (1993) Importance of mild hyperoxaluria in the pathogenesis of urolithiasis–new evidence from studies in the Arabian peninsula. Scanning Microsc 7: 391–392

Rizvi SA et al. (2002) The management of stone disease. BJU Int 89 (Suppl 1): S62–S68

Carr R (1954) A new theory on the formation of renal calculi. Br J Urol 26: 105–117

Recht PA et al. (2004) Oxalic acid alters intracellular calcium in endothelial cells. Atherosclerosis 173: 321–328

Huang HS et al. (2003) Changes in renal hemodynamics and urodynamics in rats with chronic hyperoxaluria and after acute oxalate infusion: role of free radicals. Neurourol Urodyn 22: 176–182

Borghi L et al. (1999) Essential arterial hypertension and stone disease. Kidney Int 55: 2397–2406

Toblli JE et al. (2001) Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria. J Urol 166: 275–280

Toblli JE et al. (2002) Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. J Urol 168: 1550–1555

Hackett RL et al. (1990) Cell injury associated calcium oxalate crystalluria. J Urol 144: 1535–1538

Scheid CR et al. (1996) Oxalate ion and calcium oxalate crystal interactions with renal epithelial cells. In Kidney Stones: Medical and Surgical Management, 129–143 (Eds Coe FL. et al.) Philadelphia: Lippincott–Raven

Greene EL et al. (2005) Renal cell adaptation to oxalate. Urol Res 33: 340–348

Cao LC et al. (2004) Mitochondrial dysfunction is a primary event in renal cell oxalate toxicity. Kidney Int 66: 1890–1900

Meimaridou E et al. (2006) Renal oxidative vulnerability due to changes in mitochondrial-glutathione and energy homeostasis in a rat model of calcium oxalate urolithiasis. Am J Physiol Renal Physiol 291: F731–F740

Khan SR (2005) Hyperoxaluria-induced oxidative stress and antioxidants for renal protection. Urol Res 33: 349–357

Han HJ et al. (2004) Oxalate inhibits renal proximal tubule cell proliferation via oxidative stress, p38 MAPK/JNK, and cPLA2 signaling pathways. Am J Physiol Cell Physiol 287: C1058–C1066

Umekawa T et al. (2006) Oxalate ions and calcium oxalate crystal-induced up-regulation of osteopontin and monocyte chemoattractant protein-1 in renal fibroblasts. BJU Int 98: 656–660

Huang MY et al. (2005) Oxalate stimulates IL-6 production in HK-2 cells, a line of human renal proximal tubular epithelial cells. Kidney Int 68: 497–503

Marengo SR et al. (2002) Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis. J Urol 167: 2192–2197

Grover PK et al. (2006) Renal prothrombin mRNA is significantly decreased in a hyperoxaluric rat model of nephrolithiasis. J Pathol 210: 273–281

Chen DH et al. (2004) Microarray analysis of changes in renal phenotype in the ethylene glycol rat model of urolithiasis: potential and pitfalls. BJU Int 94: 637–650

Verkoelen CF (2006) Crystal retention in renal stone disease: a crucial role for the glycosaminoglycan hyaluronan. J Am Soc Nephrol 17: 1673–1687

Marengo SR et al. (2004) Minipump induced hyperoxaluria and crystal deposition in rats: a model for calcium oxalate urolithiasis. J Urol 171: 1304–1308

Chen DH et al. (2004) Microarray analysis of changes in renal phenotype in the ethylene glycol rat model of urolithiasis: potential and pitfalls. BJU Int 94: 637–650

Jonassen JA et al. (2003) Mechanisms mediating oxalate-induced alterations in renal cell functions. Crit Rev Eukaryot Gene Expr 13: 55–72

Jeong BC et al. (2005) An animal model of calcium oxalate urolithiasis based on a cyclooxygenase 2 selective inhibitor. Urol Res 33: 453–459

Khan SR et al. (1982) Experimental calcium oxalate nephrolithiasis in the rat: role of the renal papilla. Am J Pathol 107: 59–69

Schepers MS et al. (2005) Oxalate is toxic to renal tubular cells only at supraphysiologic concentrations. Kidney Int 68: 1660–1669

Randall A (1940) The etiology of primary renal calculus. Int Abstr Surg 71: 209–240

Mo L et al. (2007) Renal calcinosis and stone formation in mice lacking osteopontin, Tamm–Horsfall protein or both. Am J Physiol Renal Physiol 293: F1935–F1943

Chau H et al. (2003) Renal calcification in mice homozygous for the disrupted type IIa Na/Pi cotransporter gene Npt2. J Bone Miner Res 18: 644–657

Bushinsky DA et al. (2001) Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 59: 1415–1423

Moochhala SH et al. (2008) Renal calcium stones: insights from the control of bone mineralization. Exp Physiol 93: 43–49

Berndt T and Kumar R (2007) Phosphatonins and the regulation of phosphate homeostasis. Annu Rev Physiol 69: 341–359

Huang C and Miller RT (2007) Regulation of renal ion transport by the calcium-sensing receptor: an update. Curr Opin Nephrol Hypertens 16: 437–443

Sayer JA et al. (2004) Nephrocalcinosis: molecular insights into calcium precipitation within the kidney. Clin Sci (Lond) 106: 549–561